Trinity Biotech plc

NASDAQ:TRIB

Medical - Diagnostics & Research

Healthcare
$5.83 -5.73%

-$0.51 today

Market cap
$117.96M
Beta
1.00
P/E (TTM)
-0.1
EPS (TTM)
-$60.27
52W Low $8.00High $103.20

Volume 0.00M

Average 1.34M

Income Statement

Follow revenue through to earnings.

Revenue

$43.78M

FY 2025 · Annual

-28.9% YoY

Operating Income

-$11.42M

FY 2025 · Annual

Net Income

-$37.38M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue81.15M62.52M56.83M61.56M43.79M
Cost of Revenue54.89M52.73M37.38M40.11M26.9M
Gross Profit33.45M22.05M19.45M21.44M16.89M
Gross Margin41.2%35.3%34.2%34.8%38.6%
Research & Development4.5M4.14M4.38M4.54M3.63M
Selling, General & Admin24.68M29.17M31.15M28.82M24.67M
Operating Expenses29.52M32.96M46.5M42.61M28.3M
Depreciation & Amortization2.74M2.33M1.78M1.87M2.68M
EBITDA10.59M(16.71M)(24.1M)(16.91M)(21.38M)
EBITDA Margin13.1%-26.7%-42.4%-27.5%-48.8%
Operating Income3.94M(15.27M)(27.05M)(21.17M)(11.42M)
Operating Margin4.9%-24.4%-47.6%-34.4%-26.1%
Interest Income1.22M303K1.17M0221K
Interest Expense7.1M24.73M10.15M9.57M13.11M
Other Income / Expenses(5.86M)(24.43M)(9.88M)(9.57M)(25.76M)
Income Before Tax(1.92M)(43.78M)(36.93M)(30.73M)(37.18M)
Pre-Tax Margin-2.4%-70.0%-65.0%-49.9%-84.9%
Income Tax Expense(74K)(194K)(59K)486K199K
Net Income875K(41M)(24.02M)(31.79M)(37.38M)
Net Margin1.1%-65.6%-42.3%-51.6%-85.4%
EPS (Basic)6.30(180.00)(96.00)(52.98)(60.00)
EPS (Diluted)4.92(156.00)(96.00)(52.98)(60.00)
Weighted Avg Shares139.34K224.9K255.17K598.65K619.19K
Weighted Avg Shares (Diluted)177.53K259.16K255.17K598.65K619.19K

TRIB Earnings Waterfall · TTM

NASDAQ:TRIB · Revenue to Net Income

Key Ratios

EPS$-60.60
Gross Margin33.7%
Net Margin-91.3%
P/E Ratio-0.5
P/S Ratio1.3

Analysis

$43.9M of revenue converted into -$37.4M of net income for the selected period. Gross margin is 33.7% and net margin is -91.3%, showing how much revenue survives after costs and taxes. EPS is $-60.60, tying the income statement back to per-share earnings.

Competitors

Peer companies in the same sector

Health

No competitor data available.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
6-K6-K filingNov 12, 2026
SC 13D/ASC 13D/A filingNov 10, 2026
6-K6-K filingOct 5, 2026
6-K6-K filingSep 9, 2026
6-K6-K filingSep 8, 2026

How much revenue does TRIB generate?

Trinity Biotech plc (TRIB) reported $43.78M of revenue in fiscal 2025.

Is TRIB profitable?

Trinity Biotech plc (TRIB) reported -$37.38M of net income, with a net margin of -85.4%.